Skip to main content
Intermediate Technical IVT

CEA

Pronunciation: C-E-A

Also written as: CEA — carcinoembryonic antigen

Carcinoembryonic antigen, a tumor marker used primarily for monitoring colorectal cancer.

Full Definition

Carcinoembryonic antigen (CEA) is a glycoprotein that serves as a tumor marker, particularly valuable in colorectal cancer management. Elevated CEA levels may indicate cancer presence, recurrence, or progression, though levels can also be elevated in benign conditions and smoking. CEA is primarily used for monitoring treatment response and detecting recurrence rather than initial diagnosis. Serial CEA measurements provide more clinical value than single determinations. In oncology documentation, CEA values should include reference ranges and trending information to aid in clinical interpretation.

Usage

Usage note: Always include units (ng/mL) and reference ranges when reporting CEA values.

In Context

  • "CEA levels decreased from 45 to 8 ng/mL following chemotherapy." — Laboratory report
  • "Rising CEA suggests possible disease recurrence in this colorectal cancer patient." — Progress note

Also known as

carcinoembryonic antigen

Don't confuse with

CA 19-9 AFP

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON